|
Sunday, May, 18, 2008
|
5:00-6:30pm Welcome Reception and Registration
|
INFORMATICS & DECISION SUPPORT TRACK
Monday, May 19, 2008
|
7:00-8:30am Registration and Breakfast
|
|
8:30 Welcome Remarks – State of the Industry and State of Symyx
Isy Goldwasser, Chief Executive Officer, Symyx Technologies, Inc.
9:00 Innovation, The Race to the Market
Wim Roels, M.Sc., Vice President, Innovation & Technology, R&D,
Borealis AG
In today’s business environment the ability to meet customers’ needs
through innovation earlier than all others is the determining success criteria.
At Borealis, we have addressed this challenge by reviewing and addressing our
innovation process and capabilities. We have addressed areas such as: decision
making, market needs identification, project management, facilities, behaviors
and high-throughput experimentation.
|
|
9:45 Networking Morning Break - Partner & Poster Displays
|
10:10 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
10:15 Having Your Cake and Eating It Too: How Vendor/Customer Collaborations
Produce a Better Electronic Laboratory Notebook
Stan Piper, B.Sc., M.B.A., Senior Scientist, Analytical R&D, Pfizer
Global Research & Development
Increasing
external pressures are forcing organizations to continuously improve
efficiencies. As the amount of data within those organizations continues to
increase, scientists need new ways to acquire, compile, search, visualize and
report that data. The use of an Electronic Laboratory Notebook (eLN) enable
scientists to meet this need. As the eLN market matures, organizations have more
choices surrounding their eLN applications. Most customers have similar drivers
behind their eLN implementations. These drivers likely go beyond simply
replacing paper based system, and organizations now look to their eLN systems to
serve as a key piece of a total lab informatics solution. Some of the more
simple drivers include fewer transcriptions and manual calculations, improved
compliance, improved IP protection, and enabling collaboration. The more complex
drivers require the eLN to: serve as an access to mine empirical data, aid in
design and planning of experiments, reduce cycle times through automation, link
to other enterprise systems such as LIMS and CDS. So with these drivers in mind,
an organization must decide which eLN product to implement, and then once chosen
must determine how to configure the application to fully realize all of these
success criteria. This presentation will discuss the current state of the
electronic lab, the issues surrounding software in the lab environment and the
importance of partnering with software vendors to develop features and functions
in an eLN.
10:45 Incorporating Symyx Notebook into a System for Recording GMP
Manufacture of Clinical Trials API with Improved Quality Management
John Leonard, Ph.D., Principal Scientist and Process Chemistry Research
Manager, AstraZeneca
We have been piloting the use of Symyx Notebook for the preparation of Batch
Instructions and Batch Records for the manufacture of clinical trials API. Process
chemists and pilot plant chemists have worked closely with QA representatives
to develop a new electronic system for transferring processes from the research
labs into GMP manufacturing facilities. The new Symyx-based system provides
a more accurate method of process transfer together with an efficient and transparent
electronic batch recording procedure. It also incorporates a completely revised
approach to batch documentation and quality management, which is based on Symyx
Vault and has led to a significant reduction in bureaucracy.
11:15 The ELN as a System Integration Platform for the Lab
Ulf Fuchslueger, Ph.D., Chief Operating Officer, Vialis GmbH
The
efficiency of data ex- and interchange is one of the key drivers for
productivity of modern laboratories in research and development. In recent years
many organisations have established ELN’s to support their research and
development labs but only in rare cases the integration aspects with other
applications and departments – especially outside the lab environment - have
been considered. This talk addresses some typical integration aspects
encountered when implementing an ELN and highlights conceptional approaches to
establish an ELN as the integration platform for the lab.
11:45 pm Birds of a Feather Breakout
Topics
|
|
|
|
12:45 Networking Lunch
|
|
1:45 Lilly’s Transition from Paper to Electronic Lab Notebooks
Keith M. DeVries, Ph.D., Director, Chemical Product R&D, Eli Lilly and
Company
|
|
2:15 Move to Track Session
|
2:25 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
2:30 The Quest for an ELN - The Need for a Reaction Management System
Danny Verbinnen, Pharma R&D IM - Research and Early Development, Johnson
& Johnson Pharmaceutical Research & Development
3:00 Integration of Electronic Notebook Software into the Workflow
of an Academic Research Group
Ulrich Jordis, Ph.D., Professor, Vienna University of Technology, Institute
of Applied Synthetic Chemistry
In our attempts to stay on top of the developments of integrating software and
databases into the daily workflow of a synthetic/medicinal chemist, we have
been using electronic notebook software (including ELAN, MDL Notebook and ChembridgeSoft
e-notebook). This talk will cover issues of usability and a wish-list for further
versions of this software that most likely will merge with other Symyx lab journal
solutions.
|
3:30 Networking Refreshment Break -
Partner & Poster Displays
|
4:00 Speed-Based Development
Kurt Swogger, Senior Consultant, Cincinnati Consulting Consortium, Retired Vice President, R&D, Dow Chemical Company
4:30 Executive Roundtable - Taking a New Approach to R&D –
Innovation, Technology & Automation
Innovation is one of the most discussed and elusive topics in business. Hear
from successful, life-long practitioners, in their own words, discuss what works,
what doesn’t and what they have learned over the business cycles. The
backdrop of Symyx Symposium will provide hands-on context to what 21st century
scientific R&D faces as industries globalize and restructure. This is an
opportunity for thought-leaders and change-agents to share experiences and practical
advice across a range of topics.
Executive Panelists:
Keith Grime, Ph.D., President, JKG Consulting, Adjunct Professor, Department
of Chemical & Biological Engineering, Northwestern University
Wim Roels, M.Sc., Vice President, Innovation & Technology, R&D, Borealis
AG
Kurt Swogger, Senior Consultant, Cincinnati Consulting Consortium, Retired Vice
President R&D, Dow Chemical Company
Klaus Kuhlein, Ph.D., Consultant, Former Head of Central Research, Hoechst AG
Keith M. DeVries, Ph.D., Director, Chemical Product R&D, Eli Lilly and
Company
Stephan Taylor, Ph.D., Director, Project & Process Optimization Systems, Process R&D, Bristol-Myers Squibb Pharmaceuticals Research Institute
5:30 End of Day
|
5:45 Assemble for Offsite Networking Reception and Dinner (Lobby Area)
|
Tuesday, May 20, 2008
|
7:30am Networking Breakfast
|
|
8:15 State of Symyx Software
Timothy Campbell, President, Symyx Software
8:30 The Disruptive Technology of Next-Generation Sequencing
Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
The ability to sequence and analyze DNA lies at the heart of biomedical research
and the pharmaceutical enterprise. Remarkably, just a few years since the completion
of the Human Genome Project, we are witnessing the birth of a number of high-throughput
– in some cases single-molecule -- DNA sequencing technologies that are
already transforming fields from medical genetics and metagenomics to paleoanthropology
and digital gene expression. These technologies harness advances in microfluidics,
nanotechnology, molecular imaging and chemical engineering to develop platforms
that, within a few years, could deliver complete human genomes in a matter of
minutes for under $1000. Already, the cost of sequencing an individual human
genome has fallen to just $60,000. Conversely, as the costs of sequencing plummet,
the prospects for truly personal genomics, as currently espoused by companies
such as 23andMe, soar, bringing with them a host of medical, ethical and privacy
challenges.
9:00 “Smart R&D”: Innovation Choices and Strategies
for a Global Marketplace
Keith Grime, Ph.D., President, JKG Consulting, Adjunct Professor, Department
of Chemical & Biological Engineering, Northwestern University
The case is presented that evolving global economic and technological dynamics
demand a change in the R&D model to compete effectively in the consumer
products sector. Key factors such as market globalization, fueled particularly
by the growth in Asian markets, sustained instability in raw material pricing
and availability, and consumer demographics in North America, Europe and Japan
place significant demands on the product development innovation process. More
choices, increased product customization and rapid reformulation capability
are all basic requirements. In parallel, the acceleration in the speed of information,
data and knowledge transfer across the globe and the expansion of knowledge
sources, mean that innovation speed, reduced internal cycles times and speed-to-market
have become basic requirements. In a world of tight budgets and uncertain costs,
R&D innovation managers must develop new, holistic innovation strategies
that can deliver more with less; more products to the market with fewer prototypes,
fewer pilot runs, less expense in qualification. There is no single magic bullet.
“Smart R&D” is required to compete in this environment calling
for smart choices in all elements of R&D strategy from core competence,
partnership effectiveness and external (or open) innovation. In “Smart
R&D”, the conventional sequential, manual approaches to the R&D
innovation process must be supplemented and replaced by virtual and digital
approaches including modeling and simulation, high-throughput technology, and
sophisticated data management systems to develop real gains in R&D productivity
while innovating to maximum capability. Disciplined choices are required in
all these areas to for effective “Smart R&D” .
|
|
9:30 Networking Coffee Break - Partner & Poster Displays
|
10:00 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
10:05 Integrating Symyx Stock Management Solution into IPSEN Information
System
Olivier Lamarche, Ph.D., International Project Manager, R&D Informatics,
Ipsen
With the prime intention of being compliant with regulatory constraints, IPSEN
has chosen Symyx Logistics to manage the life cycle of commercially available
and internal chemical products. The solution, implemented and customized by
a successful collaboration between Symyx professional services and IPSEN team,
managed H&S information and has been swiftly integrated into IPSEN information
system. Users across different departments have quickly adopted the intuitive
multi-function interface accessing related corporate and commercial databases.
10:35 Ciba’s Integrated Platform to Support Global Innovation
Process
Klaus Stumpf, Ph.D., Business Liaison I&PLM, Global Information Services,
Ciba Inc.
Within Ciba’s Research and Development (R&D), a new Global Innovation
Process (GIP) has been implemented as part of the Product Life Cycle. Now the
whole landscape of applications for the R&D community - comprising scientific
data management systems, content and document management systems, knowledge
management, and laboratory data management - has to be integrated. The basic
concept to stick all parts together is the Global Substance Identifier (GSI).
These Global Substance Identifiers and their common data for R&D will be
managed within PHOENIX, Ciba’s new R&D Information System. This system
is based on Symyx ISENTRIS. The open design of ISENTRIS makes it easy to replace
the application-oriented view of users with a business process-oriented and
content-oriented view. The user is able to focus on his/her business needs and
is no longer bothered with IT questions.
11:05 Development of Symyx Isentris 3.0 and Integration with a Registration
Tool: From Record Filing to Reporting in a While
Carlo Riva, Ph.D., Head of Chemical Synthesis, Medicinal Chemistry Department,
Pharmaceutical Research and Development Division, Recordati Industria Chimica
e Farmaceutica S.p.A.
Recordati Drug Discovery further developed its own integrated discovery informatics
system, a relatively simple system, which utilizes some default Symyx programs
and databases, joined with some custom applications, developed in collaboration
with Symyx. MDL Isentris 2.0 was migrated to Symyx Isentris 3.0, which in turn
was customized and integrated with the pre-existing custom application RecBio
(now re-written in a dotnet architecture). RecBio allows a very effective analytical,
biological or any protocol and related document management, strictly integrated
with Symyx Assay Explorer. Isentris based Custom Registration Tools were developed
to complete the entire job and allowing Recordati Drug Discovery to effectively
abandon Symyx Isis Host and Isis Desktop in the overall process of using the
proprietary databases. The overall system offers the capability of more complex
IT systems for data management. Joined to the benefits displayed by the Discovery
Gate package, it affords real benefits in term of data searching, displaying,
reporting and, finally, research productivity.
11:35 DiscoveryGate and Reference Database Web Services
Russ Hillard, Ph.D., Senior Product Manager, Symyx Software
Recent enhancements to the DiscoveryGate online content platform will be described.
Use cases will be presented that illustrate how DiscoveryGate provides direct
answers to research questions including: preparation or procurement of known
compounds, reported properties of known compounds, and synthetic methods suitable
for making novel compounds. Web service access to the Symyx Available Chemicals
Directory database will be described. Progress toward extended web service access
to all Symyx Reference Databases will be demonstrated and a roadmap for new
online content services will be presented.
1:10 Chairperson’s Remarks
Randy Clark, Vice President, Marketing, Symyx Technologies, Inc.
1:15 Symyx Software Roadmap
Trevor W. Heritage, Ph.D., Senior Vice President, Science, Symyx Software
Trevor’s presentation will discuss the exciting potential customers are
already seeing in Symyx Software’s product road map-their ability to start
in Symyx Notebook and never leave and their ability to start in Symyx Isentris
and go anywhere. Trevor will outline development plans for 2008 and 2009, specifically
addressing Symyx Notebook and Symyx Isentris, as well as Symyx Draw, ISIS, DiscoveryGate,
Automation Studio and Analysis Studio. He will also highlight specific areas
within discovery and development including: biology, catalysis, medicinal chemistry,
process, formulations and analytical. 2:15 Experiences from the Global Rollout of a Customized Logistics Application
at Boehringer Ingelheim
Georg G. Otto, Ph.D., System Analyst, Deptartment of Information Technology,
Boehringer Ingelheim Pharma GmbH & Co KG
An
efficient workflow to search, retrieve and maintain chemical reagents is a key
asset for every Pharma Company. To improve efficiency, reduce costs and satisfy
upcoming regulatory needs Boehringer was looking for a next generation Logistics
System that would replace the legacy CIMS applications and cope with changes of
interfacing hardware.
This presentation will summarize how Boehringer Ingelheim has successfully
implemented Symyx Logistics in various sites globally. Site specific
customizations at Biberach, Germany and Ridgefield, USA, as well as data
migration, technical setup of the Isentris Architecture, performance aspects and
end user training are covered. In particular the challenges in a global pharma
environment, like interface to various purchasing systems, custom prices and
automated vertical storage robotics and their implementation will be explored.
2:45 Implementation of Assay Explorer into the Drug Discovery ADME
Workflow
Thomas Arnhold, Ph.D., Principal Scientist, Department of Drug Discovery
Support, Boehringer Ingelheim GmbH & Co. KG
Microsoft Excel is the data analysis tool of choice for many labs, since it
allows flexible data analysis. However, our raw data analysis had to be adjusted
in order to
a) meet the increasing demand for ADME profiling of research compounds and
b) be able to realize an entire workflow concept from the assay request to the
delivery of calculated results.
The implementation of Assay Explorer as one unit of the whole workflow concept
for routine in vitro ADME assays will be demonstrated.
|
3:15 Networking Refreshment Break -
Partner & Poster Displays
|
3:45 Manchester Organics Catalogue Editor Showcase
James Jack, Ph.D., BSc, M.R.S.C., Senior Consultant, Symyx Technologies,
Inc.
Written using Symyx Isentris and .Net, the Manchester Organics Catalogue Editor
uses a specially extended version of the Isentris Controls to allow in place
inserts and updates to a database without the need for a specialized registration
service (it performs a simple duplicates check, but does not apply business
rules / salt stripping).
The Catalogue Editor is much more that its name suggests: it allows Manchester
Organics to not only store, search and report / print their 3000 compounds and
growing catalogue (including printing of labels), but much more than this, it
tracks pricing and quote information alongside competitors pricing, has some
integration with a SAGE accounting package and tracks batches of compounds,
their locations, the dates they were sold, etc. It also contains an MSDS authoring
tool to allow the creation of MSDS sheets for the compounds on sale in the catalogue.
This presentation will discuss how the catalogue editor was developed, its features
and uses, and future opportunities.
4:15 Notebook Integration – What’s In It For Me?
Stephen Taylor, Ph.D., Director, Project & Process Optimization Systems,
Process R&D, Bristol-Myers Squibb Pharmaceutical Research Institute
An overview of the opportunities for ELN integration leveraging notebook content
to support connectivity to existing systems and data transfer back to the ELN.
Such integration can improve the users’ productivity, eliminate duplication
of effort, eliminate errors, and provide context to data in disparate systems.
Integration should go beyond supporting existing workflows and enable scientists
to gain insights into their data. The factors that should be considered when
integrating will be reviewed, including when to integrate and when not to integrate.
4:45 Electronic Lab Notebooks, a Turning Table for Chemical/Pharmaceutical
Development Activities at Johnson and Johnson
Marijke Massy, MS, Program Manager, Janssen Pharmacuetica
In this presentation you will learn how the Electronic Lab Notebook system became
a platform supporting development activities within the global Chemical Pharmaceutical
Development Department of Johnson and Johnson, from early development up to
commercial support. You will also hear about the results of a pilot with the
Symyx Lab Execution & Experiment Analysis software, which can generate additional
benefits for the development organization.
5:15
Development of NNCD SAR and Browse with Isentris 3.0: Replacing ISIS Based
Applications
John Gregersen, Novo Nordisk A/S, and Knut Ostrom, Symyx Technologies, Inc.
Old trusted ISIS base applications tend to linger for various good reasons.
However, new generations of chemists, emerging technologies, new opportunities
for client and server side integration, and new business needs all calls for
exploitation of the opportunities provided by Isentris 3.0 software. Informatics
systems, handling molecules, have for a long period been favouring small
molecule chemists, leaving protein based research with separate specialised
tools that are not always well integrated in the more central systems. The
concepts in Isentris 3.0 open doors towards integrating these solutions into
more homogeneous user interfaces. Combined with the more modern user interface
and flexible environment this has led Novo Nordisk into starting the replacement
of central ISIS applications.
|
5:45-7pm Networking Reception
|
|
|